ADSK vs ALNY · P/E 65, rev $3.98B vs P/E 76, rev $1.29B
Autodesk Inc (ADSK) versus Alnylam Pharmaceuticals Inc (ALNY) — a side-by-side from cached financials, not a winner call.
Autodesk Inc (ADSK) is a software - application company listed on US.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Latest reported ADSK revenue for 2026-07-31 was $3.98B. Net income was $983.0M. ADSK currently screens at market cap $67.33B and trailing P/E 65.4.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
ADSK currently screens at market cap $67.33B and trailing P/E 65.4. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Not investment advice. Open the ADSK and ALNY stock pages for the full models.
Not investment advice.